These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor. Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y J Neurosurg Pediatr; 2019 Mar; 23(3):317-324. PubMed ID: 30497152 [TBL] [Abstract][Full Text] [Related]
3. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Calaminus G; Kortmann R; Worch J; Nicholson JC; Alapetite C; Garrè ML; Patte C; Ricardi U; Saran F; Frappaz D Neuro Oncol; 2013 Jun; 15(6):788-96. PubMed ID: 23460321 [TBL] [Abstract][Full Text] [Related]
4. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy. Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397 [TBL] [Abstract][Full Text] [Related]
5. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors. Nieto Y; Tu SM; Bassett R; Jones RB; Gulbis AM; Tannir N; Kingham A; Ledesma C; Margolin K; Holmberg L; Champlin R; Pagliaro L Ann Oncol; 2015 Oct; 26(10):2125-32. PubMed ID: 26199392 [TBL] [Abstract][Full Text] [Related]
6. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors. Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526 [TBL] [Abstract][Full Text] [Related]
7. Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study. Fangusaro J; Wu S; MacDonald S; Murphy E; Shaw D; Bartels U; Khatua S; Souweidane M; Lu HM; Morris D; Panigrahy A; Onar-Thomas A; Fouladi M; Gajjar A; Dhall G J Clin Oncol; 2019 Dec; 37(34):3283-3290. PubMed ID: 31545689 [TBL] [Abstract][Full Text] [Related]
8. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival. Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619 [TBL] [Abstract][Full Text] [Related]
9. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors. Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971 [TBL] [Abstract][Full Text] [Related]
10. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy. Breen WG; Blanchard MJ; Rao AN; Daniels DJ; Buckner JC; Laack NNI Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28695992 [TBL] [Abstract][Full Text] [Related]
11. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89. Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958 [TBL] [Abstract][Full Text] [Related]
12. Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience. Alapetite C; Brisse H; Patte C; Raquin MA; Gaboriaud G; Carrie C; Habrand JL; Thiesse P; Cuilliere JC; Bernier V; Ben-Hassel M; Frappaz D; Baranzelli MC; Bouffet E Neuro Oncol; 2010 Dec; 12(12):1318-25. PubMed ID: 20716594 [TBL] [Abstract][Full Text] [Related]
13. Intracranial Germ Cell Tumors in Adolescents and Young Adults: A 40-Year Multi-Institutional Review of Outcomes. Lo AC; Hodgson D; Dang J; Tyldesley S; Bouffet E; Bartels U; Cheng S; Hukin J; Bedard PL; Goddard K; Laperriere N Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):269-278. PubMed ID: 31654785 [TBL] [Abstract][Full Text] [Related]
14. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study. Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G; Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158 [TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy. Odagiri K; Omura M; Hata M; Aida N; Niwa T; Ogino I; Kigasawa H; Ito S; Adachi M; Inoue T Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):632-8. PubMed ID: 22420962 [TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation. de Rezende ACP; Weltman E; Chen MJ; Helito JK; de Carvalho ÍT; Sakuraba RK; Silva NS; Cappellano AM; Hamerschlak N PLoS One; 2019; 14(12):e0226350. PubMed ID: 31860688 [TBL] [Abstract][Full Text] [Related]
17. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study. Baek HJ; Park HJ; Sung KW; Lee SH; Han JW; Koh KN; Im HJ; Kang HJ; Park KD J Neurooncol; 2013 Sep; 114(3):329-38. PubMed ID: 23824533 [TBL] [Abstract][Full Text] [Related]
18. Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience. Lai IC; Wong TT; Shiau CY; Hu YW; Ho DM; Chang KP; Guo WY; Chang FC; Liang ML; Lee YY; Chen HH; Yen SH; Chen YW Childs Nerv Syst; 2015 May; 31(5):683-91. PubMed ID: 25749900 [TBL] [Abstract][Full Text] [Related]
19. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89]. Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864 [TBL] [Abstract][Full Text] [Related]